Literature DB >> 18452119

Role of liver transplantation in acute liver failure.

Iris W Liou1, Anne M Larson.   

Abstract

Orthotopic liver transplantation is employed as salvage therapy for individuals who are unable to recover from acute liver failure. Prognostic models are helpful but not entirely accurate in predicting those who will eventually require liver transplantation. There are specific criteria for United Network for Organ Sharing category 1a (urgent) listing of these patients. Unfortunately, clinical deterioration develops rapidly and many require removal from the waiting list prior to transplantation. With advances in critical care management and surgical technique, 1-year post-transplant survival rates have improved to 60 to 80%. Alternatives to conventional orthotopic liver transplantation include living donor liver transplantation, ABO-incompatible grafts, and auxiliary liver transplantation. There are many ethical and psychosocial issues inherent to transplanting these sick patients due to the urgent nature of acute liver failure. Fortunately, the long-term survival and quality of life in these transplant recipients is good.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452119     DOI: 10.1055/s-2008-1073119

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  16 in total

1.  Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro.

Authors:  Xiao-Lei Shi; Jin-Yang Gu; Yue Zhang; Bing Han; Jiang-Qiang Xiao; Xian-Wen Yuan; Ning Zhang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

Review 2.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

3.  Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure.

Authors:  Young-Joo Jin; Young-Suk Lim; Seungbong Han; Han Chu Lee; Shin Hwang; Sung Gyu Lee
Journal:  J Gastroenterol       Date:  2012-04-18       Impact factor: 7.527

Review 4.  Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Authors:  Mhairi C Donnelly; Peter C Hayes; Kenneth J Simpson
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 5.  Liver transplant-psychiatric and psychosocial aspects.

Authors:  Sandeep Grover; Siddharth Sarkar
Journal:  J Clin Exp Hepatol       Date:  2012-12-16

Review 6.  Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?

Authors:  Burcin Ekser; Bruno Gridelli; A Joseph Tector; David K C Cooper
Journal:  Transplantation       Date:  2009-11-15       Impact factor: 4.939

Review 7.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

Review 8.  Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review.

Authors:  Byung Woog Kang; Soo Jung Lee; Joon Ho Moon; Shi-Nae Kim; Yee Soo Chae; Jong Gwang Kim; Yoon-Jin Hwang; Sang-Kyun Sohn
Journal:  Int J Hematol       Date:  2009-07-30       Impact factor: 2.490

9.  Bifunctional polyethersulfone hollow fiber with a porous, single-layer skin for use as a bioartificial liver bioreactor.

Authors:  Shichang Zhang; Tao Liu; Li Chen; Mingliang Ren; Bo Zhang; Zhengguo Wang; Yingjie Wang
Journal:  J Mater Sci Mater Med       Date:  2012-05-15       Impact factor: 3.896

10.  Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.

Authors:  Geert A A Nibourg; Robert A F M Chamuleau; Tessa V van der Hoeven; Martinus A W Maas; An F C Ruiter; Wouter H Lamers; Ronald P J Oude Elferink; Thomas M van Gulik; Ruurdtje Hoekstra
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.